DNA-dependent protein kinase catalytic subunit modulates the stability of c-Myc oncoprotein

Molecular Cancer

Volumn 7, Issue , 2008, Pages

  An, Jing ^a   Yang, Dong Yan ^a   Xu, Qin Zhi ^a   Zhang, Shi Meng ^a   Huo, Yan Ying ^a   Shang, Zeng Fu ^a   Wang, Yu ^a   Wu, De Chang ^a   Zhou, Ping Kun ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; DNA DEPENDENT PROTEIN KINASE; GLYCOGEN SYNTHASE KINASE 3; MYC PROTEIN; PROTEIN KINASE B; SERINE; SMALL INTERFERING RNA; THREONINE; MYC PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; PRKDC PROTEIN, HUMAN;

ARTICLE; CELL PROLIFERATION; CELL STRAIN HEPG2; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVE SITE; GENE SILENCING; GENETIC TRANSFECTION; GLIOMA CELL; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; UBIQUITINATION; GENETICS; GENOMIC INSTABILITY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

CELL PROLIFERATION; DNA-ACTIVATED PROTEIN KINASE; DOWN-REGULATION; GENOMIC INSTABILITY; GLYCOGEN SYNTHASE KINASE 3; HELA CELLS; HUMANS; NUCLEAR PROTEINS; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MYC; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 43949112650     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-7-32     Document Type: Article

References (48)

1. Grandori C Cowley SM James LP Eisenman RN The Myc/Max/Mad network and the transcriptional control of cell behavior Annu Rev Cell Dev Biol 2000, 16:653-699. 10.1146/annurev.cellbio.16.1.653 11031250
2. Park K Kwak K Kim J Lim S Han S c-myc amplification is associated with HER2 amplification and closely linked with cell proliferation in tissue microarray of nonselected breast cancers Hum Pathol 2005, 36:634-639. 10.1016/j.humpath.2005.04.016 16021569
3. Shachaf CM Kopelman AM Arvanitis C Karlsson A Beer S Mandl S Bachmann MH Borowsky AD Ruebner B Cardiff RD Yang Q Bishop JM Contag CH Felsher DW MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer Nature 2004, 431:1112-1117. 10.1038/ nature03043 15475948
4. Chrzan P Skokowski J Karmolinski A Pawelczyk T Amplification of c-myc gene and overexpression of c-Myc protein in breast cancer and adjacent non-neoplastic tissue Clinical Biochemistry 2001, 34:557-562. 10.1016/ S0009-9120(01)00260-0 11738392
5. Naidu R Wahab NA Yadav M Kutty MK Protein expression and molecular analysis of c-myc gene in primary breast carcinoma using immunohistochemistry and differential polymerase chain reaction Int J Mol Med 2002, 9:189-196. 11786932
6. Nesbit CE Tersak JM Prochownik EV MYC oncogenes and human neoplastic disease Oncogene 1999, 18:3004-3016. 10.1038/sj.onc.1202746 10378696
7. Oster SK Ho CS Soucie EL Penn LZ The myc oncogene: Marvelously complex Adv Cancer Res 2002, 84:81-154. 11885563
8. Paganano KB Vassallo J Lorand-Metze I Costa FF Saad ST p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas Am J Hematol 2001, 67:84-92. 10.1002/ajh.1084 11343379
9. Tokumoto N Ikeda S Ishizaki Y Kurihara T Ozaki S Iseki M Shimizu Y Itamoto T Arihiro K Okajima M Asahara T Immunohistochemical and mutational analyses of Wnt signaling components and target genes in intrahepatic cholangiocarcinomas Int J Oncol 2005, 27:973-980. 16142313
10. Salghetti SE Kim SY Tansey WP Destruction of myc by ubiquitin-mediated proteolysis: Cancer-associated and transforming mutations stabilize myc The EMBO Journal 1999, 18:717-726. 1171164 9927431 10.1093/emboj/18.3.717
11. Amati B Myc degradation: Dancing with ubiquitin ligases Proc Natl Acad Sci USA 2004, 101:8843-8844. 428433 15187232 10.1073/pnas.0403046101
12. Gregory MA Hann SR c-Myc proteolysis by the ubiquitin-proteasome pathway: Stabilization of c-Myc in Burkitt's lymphoma cells Mol Cell Biol 2000, 20:2423-2435. 85426 10713166 10.1128/MCB.20.7.2423-2435.2000
13. Kim SY Herbst A Tworkowski KA Salghetti SE Tansey WP Skp2 regulates myc protein stability and activity Molecular Cell 2003, 11:1177-1188. 10.1016/S1097-2765(03)00173-4 12769843
14. Lehr von der N Johansson S Wu S Bahram F Castell A Cetinkaya C Hydbring P Weidung I Nakayama K Nakayama KI Soderberg O Kerppola TK Larsson LG The F-box protein Skp2 participates in c-myc proteosomal degradation and acts as a cofactor for c-myc-regulated transcription Molecular Cell 2003, 11:1189-1200. 10.1016/S1097-2765(03)00193-X 12769844
15. Welcker M Orian A Jin J Grim JE Harper JW Eisenman RN Clurman BE The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation Proc Natl Acad Sci USA 2004, 101:9085-9090. 428477 15150404 10.1073/pnas.0402770101
16. Flinn EM Busch CM Wright AP myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome Mol Cell Biol 1998, 18:5961-5969. 109182 9742113
17. Sears R Nuckolls F Haura F Taya Y Tamai K Nevins JR Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability Gene Dev 2000, 14:2501-2514. 316970 11018017 10.1101/gad.836800
18. Gregory MA Qi Y Hann SR Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear location J Biol Chem 2003, 278:51606-51612. 10.1074/jbc.M310722200 14563837
19. Bahram F Lehr von der N Cetinkaya C Larsson LG c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover Blood 2000, 95:2104-2110. 10706881
20. Jackson SP Sensing and repairing DNA double-strand breaks Carcinogenesis 2002, 23:687-696. 10.1093/carcin/23.5.687 12016139
21. Park SJ Oh EJ Yoo MA Lee SH Involvement of DNA-dependent protein kinase in regulation of stress-induced JNK activation DNA Cell Biol 2001, 20:637-645. 10.1089/104454901753340622 11749722
22. Bailey SM Brenneman MA Halbrook J Nickoloff JA Ullrich RL Goodwin EH The kinase activity of DNA-PK is required to protect mammalian telomeres DNA Repair (Amst) 2004, 3:225-233. 10.1016/j.dnarep.2003.10.013 15177038
23. Hande MP DNA repair factors and telomere-chromosome integrity in mammalian cells Cytogenet Genome Res 2004, 104:116-122. 10.1159/ 000077475 15162024
24. Hosoi Y Tatanabe W Nakagawa K Matsumoto Y Enomoto A Morita A Nagawa H Suzuki N Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer Int J Oncol 2004, 25:461-468. 15254745
25. Nguyen DC Parsa B Close A Magnusson B Crowe DL Sinha UK Overexpression of cell cycle regulatory proteins correlates with advanced tumor stage in head and neck squamous cell carcinomas Int J Oncol 2003, 22:285-1290.
26. Sakata K Matsumoto Y Satoh H Oouchi A Nagakura H Koito K Hosoi Y Hareyama M Suzuki N Clinical studies of immunohistochemical staining of DNA-dependent protein kinase in oropharyngeal and hypopharyngeal carcinomas Radiat Med 2001, 19:93-97. 11383649
27. Shintani S Mihara M Li C Nakahara Y Hino S Nakashiro K Hamakawa H Up-regulation of DNA-dependent protein kinase correlates with radiation resistance in oral squamous cell carcinoma Cancer Sci 2003, 94:894-900. 10.1111/j.1349-7006.2003.tb01372.x 14556663
28. Stronati L Gensabella G Lamberti C Barattini P Frasca D Tanzarella C Giacobini S Toscano MG Santacroce C Danesi DT Expression and DNA binding activity of the Ku heterodimer in bladder carcinoma Cancer 2001, 92:2484-2492. 10.1002/ 1097-0142(20011101)92:9<2484::AID-CNCR1598>3.0.CO;2-7 11745306
29. Yu ZJ Sui JL Ding YQ Cao ZS Zhou PK Wu DC Expression of DNA-PK in hepato- and cholangio-neoplasms and its significance Zhonghua Gan Zang Bing Za Zhi 2004, 12(11):652-655. 15623371
30. Tonotsuka N Hosoi Y Miyazaki S Miyata G Sugawara K Mori T Ouchi N Satomi S Matsumoto Y Nakagawa K Miyagawa K Ono T Heterogeneous expression of DNA-dependent protein kinase in esophageal cancer and normal epithelium Int J Mol Med 2006 18 441 447 16865228
31. Moll U Lau R Sypes MA Gupta MM Anderson CW DNA-PK, the DNA-activated protein kinase, is differentially expressed in normal and malignant human tissues Oncogene 1999, 18:3114-3126. 10.1038/sj.onc.1202640 10340383
32. Oka A Takashima S Abe M Araki R Takeshita K Expression of DNA-dependent protein kinase catalytic subunit and Ku80 in developing human brains: implication of DNA-repair in neurogenesis Neurosci Lett 2000, 292:167-170. 10.1016/S0304-3940(00)01462-2 11018303
33. Sallmyr A Miller A Gabdoulkhakova A Safronova V Henriksson G Bredberg A Expression of DNA-dependent protein kinase in human granulocytes Cell Res 2004, 14:331-340. 10.1038/sj.cr.7290233 15353130
34. Holgersson A Erdal H Nilsson A Lewensohn R Kanter L Expression of DNA-PKcs and Ku86, but not Ku70, differs between lymphoid malignancies Exp Mol Pathol 2004, 77:1-6. 10.1016/j.yexmp.2004.02.001 15215044
35. An J Xu QZ Sui JL Bai B Zhou PK Down-regulation of c-myc protein by siRNA-mediated silencing of DNA-PKcs in HeLa cells Int J Cancer 2005, 117:531-537. 10.1002/ijc.21093 15929110
36. An J Xu QZ Sui JL Bai B Zhou PK Silencing of DNA-PKcs alters the transcriptional profile of certain signal transduction genes related to proliferation and differentiation in HeLa cells Int J Mol Med 2005, 16:455-462. 16077955
37. Peng Y Woods RG Beamish H Ye R Lees-Miller SP Lavin MF Bedford JS Deficiency in the catalytic subunit of DNA-dependent protein kinase causes down-regulation of ATM Cancer Res 2005, 65:1670-1677. 10.1158/ 0008-5472.CAN-04-3451 15753361
38. Fukushima S Kinoshita A Puatanachokchai R Kushida M Wanibuchi H Morimura K Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens Carcinogenesis 2005, 26:1835-1845. 10.1093/carcin/bgi160 15975961
39. Calabrese EJ Cancer biology and hormesis: Human tumor cell lines commonly display hormetic (biphasic) dose responses Crit Rev Toxicol 2005, 35:463-582. 10.1080/10408440591034502 16422392
40. Corzo C Corominas JM Tusquets I Salido M Bellet M Fabregat X Serrano S Sole F The MYC oncogene in breast cancer progression: From benign epithelium to invasive carcinoma Cancer Genet Cytogenet 2006, 165:151-156. 10.1016/j.cancergencyto.2005.08.013 16527609
41. Dimova I Raitcheva S Dimitrov R Doganov N Toncheva D Correlations between c-myc gene copy-number and clinicopathological parameters of ovarian tumours Eur J Cancer 2006, 42:674-679. 10.1016/ j.ejca.2005.11.022 16458500
42. Dews M Homayouni A Yu D Murphy D Sevignani C Wentzel E Furth EE Lee WM Enders GH Mendell JT Thomas-Tikhonenko A Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster Nature Genet 2006, 38:1060-1065. 10.1038/ng1855 16878133
43. Burbano RR Assumpcao PP Leal MF Calcagno DQ Guimaraes AC Khayat AS Takeno SS Chen ES De Arruda Cardoso Smith M C-MYC locus amplification as metastasis predictor in intestinal-type gastric adenocarcinomas: CGH study in Brazil Anticancer Res 2006, 26:2909-2914. 16886612
44. Chan KL Guan XY Ng IO High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma Hum Pathol 2004, 35:1324-1331. 10.1016/j.humpath.2004.06.012 15668888
45. Um JH Kwon JK Kang CD Kim MJ Ju DS Bae JH Kim DW Chung BS Kim SH Relationship between antiapoptotic molecules and metastatic potency and the involvement of DNA-dependent protein kinase in the chemosensitization of metastatic human cancer cells by epidermal growth factor receptor blockade J Pharmacol Exp Ther 2004, 311:1062-1070. 10.1124/jpet.104.070938 15273254
46. Feng J Park J Cron P Hess D Hemmings BA Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase J Biol Chem 2004, 279:41189-41196. 10.1074/jbc.M406731200 15262962
47. Yamaguchi K Lee SH Eling TE Baek SJ Identification of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) as a novel downstream target of phosphatidylinositol 3-kinase/AKT/GSK-3β pathway J Biol Chem 2004, 279:49617-49623. 10.1074/jbc.M408796200 15377673
48. Slezak BP Hatch GE DeVito MJ Diliberto JJ Slade R Crissman K Hassoun E Birnbaum LS Oxidative stress in female B6C3F1 mice following acute and subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) Toxicol Sci 2000, 54:390-398. 10.1093/toxsci/54.2.390 10774821